Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00398463Phase 4Completed
Phase 4, randomised, double-blind trial in coronary artery disease (CAD) comparing Tirofiban with Placebo (2 arms). Primary endpoint: Troponin I or T elevation ratio at 48 hours. Started May 2006; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00398463.